APT drug R&D: the right active ingredient in the right presentation for the right therapeutic use.
- Published in:
- 2009
- By:
- Publication type:
- review
Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 11
Results: 24
1
2
New medicines to improve control and contribute to the eradication of malaria.
- Published in:
- 2009
- By:
- Publication type:
- journal article
3
A pre-emptive strike against malaria's stealthy hepatic forms.
- Published in:
- 2009
- By:
- Publication type:
- journal article
4
Can literature analysis identify innovation drivers in drug discovery?
- Published in:
- 2009
- By:
- Publication type:
- review
5
Targeting protein kinases in central nervous system disorders.
- Published in:
- 2009
- By:
- Publication type:
- journal article
6
Influenza vaccine market dynamics.
- Published in:
- 2009
- By:
- Publication type:
- journal article
7
Asenapine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
8
Nanotechnology.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 911, doi. 10.1038/nrd3029
- Publication type:
- Article
9
Metabolic disease: Dual benefit of bile acid receptor agonist.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 848, doi. 10.1038/nrd3032
- By:
- Publication type:
- Article
10
Antibacterial drugs: Proteasome target to tackle non-replicating TB.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 845, doi. 10.1038/nrd3033
- By:
- Publication type:
- Article
11
Cancer: CpG–siRNA deals double blow to tumours.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 847, doi. 10.1038/nrd3034
- By:
- Publication type:
- Article
12
HIV: A new starting point for HIV vaccine design.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 846, doi. 10.1038/nrd3035
- By:
- Publication type:
- Article
13
Mood disorders: Antidepressant action through gene regulation.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 847, doi. 10.1038/nrd3036
- By:
- Publication type:
- Article
14
In brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 848, doi. 10.1038/nrd3037
- Publication type:
- Article
15
Deal watch: Nektar in US$1.5 billion licensing deal with AstraZeneca.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 836, doi. 10.1038/nrd3038
- Publication type:
- Article
16
Trial watch: CGRP receptor antagonist meets Phase III migraine end points.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 836, doi. 10.1038/nrd3039
- Publication type:
- Article
17
Market watch: Sales of biologics to show robust growth through to 2013.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 837, doi. 10.1038/nrd3040
- By:
- Publication type:
- Article
18
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 827, doi. 10.1038/nrd3041
- Publication type:
- Article
19
Steering for success.
- Published in:
- 2009
- Publication type:
- Editorial
20
First oral therapies for multiple sclerosis anticipated.
- Published in:
- 2009
- By:
- Publication type:
- journal article
21
Novel pharmacotherapies for obesity poised to enter market.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 833, doi. 10.1038/nrd3044
- By:
- Publication type:
- Article
22
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 11, p. 835, doi. 10.1038/nrd3045
- Publication type:
- Article
23
Patent watch. Drug metabolite claims are patentable.
- Published in:
- 2009
- By:
- Publication type:
- journal article
24
Frank Douglas.
- Published in:
- 2009
- Publication type:
- Interview